The ins (cell) and outs (plasma) of apolipoprotein A-V

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Forte, Trudy M ^a   Shu, Xiao ^a,b   Ryan, Robert O ^a,b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein A V intracellular trafficking; Apolipoprotein A V lipid binding; Apolipoprotein A V lipid droplet association; Apolipoprotein A V molecular structure; Apolipoprotein A V mutants; Heparan sulfate proteoglycans

Indexed keywords

APOLIPOPROTEIN A; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; CHEMISTRY; EXTRACELLULAR SPACE; HUMAN; INTRACELLULAR SPACE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; APOLIPOPROTEINS A; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; EXTRACELLULAR SPACE; HUMANS; INTRACELLULAR SPACE; TRIGLYCERIDES;

EID: 66349097499     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800050-JLR200     Document Type: Review

References (46)

1. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J-C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173. (Pubitemid 32952971)
2. Van der Vliet, H. N., M. G. Sammels, A. C. J. Leegwater, J. H. M. Levels, P. H. Reitsma, W. Boers, and R. A. F. M. Chamuleau. 2001. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276: 44512-44520.
3. Farrell, G. C. 2004. Probing Prometheus: fat fueling the fire? Hepatology. 40: 1252-1255. (Pubitemid 39656997)
4. Shteyer, E., Y. Liao, L. J. Muglia, P. S. Hruz, and D. A. Rudnick. 2004. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 40: 1322-1332. (Pubitemid 39657006)
5. Pennacchio, L. A., M. Olivier, J. A. Hubacek, R. M. Krauss, E. M. Rubin, and J. C. Cohen. 2002. Two independent aplipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11: 3031-3038. (Pubitemid 35414816)
6. Talmud, P. J., S. Martin, M. R. Taskinen, M. H. Frick, M. S. Nieminen, Y. A. Kesaniemi, A. Pasternack, S. E. Humphries, and M. Syvanne. 2004. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary hear disease: results from the LOCATstudy. J. Lipid Res. 45: 750-756. (Pubitemid 38405682)
7. Nabika, T., S. Nasreen, S. Kobayashi, and J. Masuda. 2002. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis. 165: 201-204. (Pubitemid 35333346)
8. Vrablik, M., A. Horinek, R. Ceska, V. Adamkova, R. Poledne, and J. A. Hubacek. 2003. Ser19>Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people. J. Med. Genet. 40: e105.
9. Hodoglugil, U., S. Tanyolac, D.W. Williamson, Y. Huang, and R.W. Mahley. 2005. Apolipoprotein A5: a potential modulator of plasma triglyceride levels in Turks. J. Lipid Res. 47: 144-153.
10. Talmud, P. J., J. Palmen, W. Putt, L. Lins, and S. E. Humphries. 2005. Determination of the functionality of common APOA5 polymorphisms. J. Biol. Chem. 280: 28215-28220. (Pubitemid 41105717)
11. Ahituv, N., J. Akiyama, A. Chapman-Helleboid, J. Fruchart, and L. A. Pennacchio. 2007. In vivo characterization of human APOA5 haplotypes. Genomics. 90: 674-679. (Pubitemid 350166831)
12. Mansouri, R. M., E. Bauge, P. Gervois, J. Fruchart-Najib, C. Fievet, B. Staels, and J. C. Fruchart. 2008. Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia. Circ. Res. 103: 450-453.
13. O'Brien, P. J., W. E. Alborn, J. H. Sloan, M. Ulmer, A. Boodhoo, M. D. Knierman, A. E. Schultze, and R. J. Konrad. 2005. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin. Chem. 51: 351-359. (Pubitemid 40175805)
14. Ishihara, M., T. Kujiraoka, T. Iwasaki, M. Nagano, M. Takano, J. Ishii, M. Tsuji, H. Ide, I. P. Miller, N. E. Miller, et al. 2005. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J. Lipid Res. 46: 2015-2022. (Pubitemid 41248499)
15. Schaap, F. G., M. C. Nierman, J. F. P. Berbée, H. Hattori, P. J. Talmud, S. F. C. Vaessen, P. C. N. Rensen, R. A. F. M. Chamuleau, J. A. Kuivenhoven, and A. K. Groen. 2006. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. J. Lipid Res. 47: 2333-2339. (Pubitemid 44936144)
16. Talmud, P. J., J. A. Cooper, H. Hattori, I. P. Miller, G. J. Miller, and S. E. Humphries. 2006. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia. 49: 2337-2340. (Pubitemid 44359094)
17. Vaessen, S. F. C., F. G. Schaap, J-A. Kuivenhoven, A. K. Groen, B. A. Hutten, S. M. Boekholdt, H. Hattori, M. S. Sandhu, S. A. Bingham, R. Luben, et al. 2006. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study. J. Lipid Res. 47: 2064-2070. (Pubitemid 44401995)
18. van der Vliet, H. N., F. G. Schaap, J. H. M. Levels, R. Ottenhoff, N. Looije, J. G. Wesseling, A. K. Groen, and R. A. F. M. Chamuleau. 2002. Adenoviral overexpression of apolipoproein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem. Biophys. Res. Commun. 295: 1156-1159.
19. Qu, S., G. Perdomo, D. Su, F. M. D'Souza, N. S. Shachter, and H. H. Dong. 2007. Effects of apoA-V on HdL and VLDl metabolism in APOC3 transgenic mice. J. Lipid Res. 48: 1476-1487. (Pubitemid 47312010)
20. Dallinga-Thie, G. M., A. van Tol, H. Hattori, L. C. van Vark-van der Zee, H. Jansen, and E. J. G. Sijbrands. 2006. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia. 49: 1505-1511. (Pubitemid 43848086)
21. Nelbach, L., X. Shu, R. J. Konrad, R. O. Ryan, and T. M. Forte. 2008. Effect of apolipoprotein A-Von plasma triglyceride, lipoprotein size and composition in genetically engineered mice. J. Lipid Res. 49: 572-580.
22. Shu, X., J. Chan, R. O. Ryan, and T. M. Forte. 2007. Apolipoprotein A-V association with intracellular lipid droplets. J. Lipid Res. 48: 1445-1450. (Pubitemid 47312006)
23. Alborn, W. E., M. G. Johnson, M. J. Prince, and R. J. Konrad. 2006. Definitive N-terminal protein sequence and further characterization of the novel apolipoprotein A5 in human serum. Clin. Chem. 52: 514-517.
24. Beckstead, J. A., M. N. Oda, D. D. O. Martin, T. M. Forte, J. K. Bielicki, T. Berger, R. Luty, C. M. Kay, and R. O. Ryan. 2003. Structure-function studies of human Apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry. 42: 9416-9423. (Pubitemid 36959249)
25. Beckstead, J. A., K. Wong, V. Gupta, C-P. L. Wan, V. R. Cook, R. B. Weinberg, P. M. M. Weers, and R. O. Ryan. 2007. The effect of C-terminal truncation on the structural and lipid binding properties of apolipoprotein A-V. J. Biol. Chem. 282: 15484-15489.
26. Wong, K., D. Lee, J. A. Beckstead, P. M. M. Weers, C. M. Kay, and R. O. Ryan. 2008. The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture. Biochemistry. 33: 8768-8774.
27. Lookene, A., J. A. Beckstead, S. Nilsson, G. Olivecrona, and R. O. Ryan. 2005. Apolipoprotein A-V heparin interactions: implications for plasma lipoprotein metabolism. J. Biol. Chem. 280: 25383-25387. (Pubitemid 40962241)
28. Merkel, M., B. Loeffler, M. Kluger, N. Fabig, G. Geppert, L. A. Pennacchio, A. Laatsch, and J. Heeren. 2005. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J. Biol. Chem. 280: 21553-21560. (Pubitemid 40805722)
29. Nilsson, S. K., A. Lookene, J. A. Beckstead, G. Gliemann, R. O. Ryan, and G. Olivecrona. 2007. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry. 46: 3896-3904. (Pubitemid 46493490)
30. Kao, J. T., H. C. Wen, K. L. Chien, H. C. Hsu, and S. W. Lin. 2003. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum. Mol. Genet. 12: 2533-2539.
31. Tang, Y., P. Sun, D. Guo, A. Ferro, Y. Ji, Q. Chen, and L. Fan. 2006. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis. 185: 433-437.
32. Pullinger, C. R., B. E. Aouizerat, I. Movsesyan, V. Durlach, E. J. Sijbrands, K. Nakajima, A. Poon, G. M. Dallinga-Thie, H. Hattori, L. L. Green, et al. 2008. An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J. Lipid Res. 49: 1846-1854.
33. Grosskopf, I., N. Baroukh, S. J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper. 2005. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. Biol. 25: 2573-2579. (Pubitemid 43732281)
34. Dichlberger, A., L. A. Cogburn, J. Nimpf, and W. J. Schneider. 2007. Avian apolipoprotein A-V binds to LDL receptor gene family members. J. Lipid Res. 48: 1451-1456. (Pubitemid 47312007)
35. Nilsson, S. K., S. Christensen, M. K. Raarup, R. O. Ryan, M. S. Nielsen, and G. Olivecrona. 2008. Endocytosis of apolipoprotein AV by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J. Biol. Chem. 283: 25920-25927.
36. Beigneux, A. P., B. Davies, P. Gin, M. M. Weinstein, E. Farber, X. Qiao, F. Peale, S. Bunting, R. L. Walzem, J. S. Wong, et al. 2007. Glycosylphosphatidyl-inositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5: 279-291. (Pubitemid 46477852)
37. Gin, P., L. Yin, B. S. J. Davies, M. M. Weinstein, A. Bensadoun, R. O. Ryan, L. G. Fong, S. G. Young, and A. P. Beigneux. 2008. The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J. Biol. Chem. 283: 29554-29562.
38. Schaap, F. G., P. C. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. van Dijk. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein- triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947. (Pubitemid 38900062)
39. Fruchart-Najib, J., E. Bauge, L. Sniculescu, T. Pham, B. Thomas, C. Rommens, Z. Majd, B. Brewer, L. A. Pennacchio, and J-C. Furchart. 2004. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem. Biophys. Res. Commun. 319: 397-404. (Pubitemid 38725960)
40. Chan, D. C., G. F. Watts, M. N. Nguyen, and P. H. R. Barrett. 2006. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Arterioscler. Thromb. Vasc. Biol. 26: 590-596.
41. Shu, X., R. O. Ryan, and T. M. Forte. 2008. Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment. J. Lipid Res. 49: 1670-1676.
42. Lamant, M., F. Smih, R. Harmancey, P. Philip-Couderc, A. Pathak, J. Roncalli, M. Galinier, X. Collet, P. Massabuau, J. Senard, et al. 2006. ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J. Biol. Chem. 281: 36289-36302. (Pubitemid 46041364)
43. Hickenbottom, S. J., A. R. Kimmel, C. Londos, and J. H. Hurley. 2004. Structure of a lipid droplet protein: the PAT family member TIP47. Structure. 12: 1199-1207. (Pubitemid 38900762)
44. Martin, S., and R. G. Parton. 2006. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7: 373-378.
45. Ory, D. S. 2007. Chylomicrons and lipoprotein lipase at the endothelial surface: bound and GAG-ged? Cell Metab. 5: 229-231. (Pubitemid 46477857)
46. Wong, K., and R. O. Ryan. 2007. Characterizatioin of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Curr. Opin. Lipidol. 18: 319-324. (Pubitemid 46743057)